Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable ATP-dependent RNA helicase DDX47 is a member of the DEAD box protein family, characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif and known for functions in ATP-dependent RNA unwinding[1][2][3][5]. DDX47 plays important roles in ribosome biogenesis, particularly rRNA processing in the nucleolus, and may also participate in mRNA splicing, translation initiation, and apoptosis[1][3]. It can shuttle between the nucleus and cytoplasm and possesses RNA-independent ATPase activity[1]. This protein is also indirectly implicated in disease processes including cancer and viral infection, for example as a host factor manipulated by HIV-1 for optimal viral RNA metabolism[3]. No specific small molecule inhibitors or therapeutic drugs directly targeting DDX47 have been reported.
ATP-dependent RNA unwinding; RNA-protein complex remodeling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX47 (DDX47).